The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics

The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristics

Background: The ONTARGET and TRANSCEND clinical trials were designed to investigate the cardioprotective effects of telmisartan 80 mg and ramipril 10 mg, alone and in combination, in patients at high risk of cardiovascular disease. Cardiac MRI enables investigation of mechanistic effects of these ag...

Full description

Bibliographic Details
Main Authors: Cowan, B., Young, A., Anderson, C., Doughty, R., Krittayaphong, R., Lonn, E., Marwick, T., Reid, Christopher, Sanderson, J., Schmieder, R., Teo, K., Wadham, A., Worthley, S., Yu, C., Yusuf, S., Jennings, G.
Format: Journal Article
Published: 2009
Online Access:http://hdl.handle.net/20.500.11937/44733

Internet

http://hdl.handle.net/20.500.11937/44733

Similar Items